학술논문

Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2− metastatic breast cancer patients receiving palbociclib and endocrine therapy: primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial
Document Type
Article
Source
In Annals of Oncology August 2023 34(8):660-669
Subject
Breast tumors
Language
ISSN
0923-7534